-
Business
-
Policy & Business
-
-
Federal IT
-
Information Technology
-
-
State & Local
-
State & Local Government
-
-
Defense
-
Defense & Intelligence
-
-
Healthcare
-
Healthcare Policy & IT
-
-
Energy
-
Energy Policy & Technology
-
-
Education
-
Education Policy & Technology
-
Hepatitis C cases spiked after Oxycontin reformulated to deter opioid abuse
Modern Healthcare: New research finds one of the most successful moves to reduce the risk of prescription opioid abuse may have inadvertently led to a spike in hepatitis C infections, and potentially, healthcare costs.
The rate of hepatitis C infection in the U.S. had been relatively stagnant before 2010, according to a study published Monday in Health Affairs, even as the rate of death from prescription opioid overdose rose. That year, makers of the pain-reliever OxyContin changed the drug formula to make it less addictive.
Tags
Share
Top Stories
- Lacking statewide vaccine plan, Florida counties turn to Eventbrite
- CIOs and CTOs look to cloud for infrastructure modernization
- Health IT execs offer thoughts on the big issues of 2021
- Emotet Malware Returns with 100K Daily Emails, New Evasion Tactics
- OCR issues guidance on disclosure of protected info using health information exchanges
- What healthcare orgs should be doing in response to the SolarWinds breach
- Inside Amazon's efforts to build a national telehealth business geared toward big employers
- Telehealth poses big cybersecurity dangers, Harvard researchers warn
- Third-Party Vendor Dental Care Alliance Breach Impacts 1M Patients
- At one urban health center, ‘regulatory change was critical’ to telehealth success
- What's next for cybersecurity in 2021? Ransomware-as-a-service, DDoS and more
- Montana Hospital Group to Pay $4.2M After Breach Lawsuit
- Bipartisan Cadre of Lawmakers Call for Permanent Telehealth Expansion
- As vaccine rollout looms, so do big questions around supply chains
- Hackers taking aim at crucial COVID-19 vaccine 'cold chain,' says IBM
- GIS data will be critical for successful vaccine distribution
Whitepapers & Special Reports
i360Gov Newsletters
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe NowAlso in Healthcare Policy & IT
About
i360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Contact Us
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
Newsletters
Copyright © 2009-2024 i360Communications, LLC.